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Abstract
Background: The Mycobacterium tuberculosis genome encodes two peptide transporters encoded by Rv3665c-Rv3662c and
Rv1280c-Rv1283c. Both belong to the family of ABC transporters containing two nucleotide-binding subunits, two integral
membrane proteins and one substrate-binding polypeptide. However, little is known about their functions in M. tuberculosis.H e r e
we report functional characterization of the Rv1280c-Rv1283c-encoded transporter and its substrate-binding polypeptide OppAMTB.
Methodology/Principal Findings: OppAMTB was capable of binding the tripeptide glutathione and the nonapeptide
bradykinin, indicative of a somewhat broad substrate specificity. Amino acid residues G109, N110, N230, D494 and F496,
situated at the interface between domains I and III of OppA, were required for optimal peptide binding. Complementaton of
an oppA knockout mutant of M. smegmatis with OppAMTB confirmed the role of this transporter in importing glutathione
and the importance of the aforesaid amino acid residues in peptide transport. Interestingly, this transporter regulated the
ability of M. tuberculosis to lower glutathione levels in infected compared to uninfected macrophages. This ability was partly
offset by inactivation of oppD. Concomitantly, inactivation of oppD was associated with lowered levels of methyl glyoxal in
infected macrophages and reduced apoptosis-inducing ability of the mutant. The ability to induce the production of the
cytokines IL-1b, IL-6 and TNF-a was also compromised after inactivation of oppD.
Conclusions: Taken together, these studies uncover the novel observations that this peptide transporter modulates the
innate immune response of macrophages infected with M. tuberculosis.
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Introduction
ATP binding cassette (ABC) transporters are found both in
eukaryotes and prokaryotes, and play important roles in the
transport of ions, amino acids, peptides, proteins, etc. [1]. ABC
transporters may be importers or exporters depending on the
direction in which they transport substrates [2]. Importers are
found exclusively in prokaryotes and include the oligopeptide
transporter systems [3–6].
The oligopeptide importers consist of five subunits: two
homologous integral membrane proteins OppB and OppC which
form the translocation pore, two nucleotide-binding domains
OppD and OppF and the substrate-binding lipoprotein (SBP)
OppA that determines substrate specificity. In Gram-positive
bacteria SBPs are soluble proteins residing in the periplasm. They
are either anchored to the membrane through a lipid modification
on the N-terminal cysteine or covalently linked to the translocation
pore [7]. Crystal structures are available for the dipeptide-binding
protein DppA from E. coli [8], OppA from Salmonella typhimurium
[9], OppA from Yersinia pestis [10], AppA from Bacillus subtilis [11]
and OppA from Lactococcus lactis [12]. The structures explain the
promiscuity of the proteins for peptide binding. The binding
pockets are fairly large. Substrate binding is determined by
hydrogen bonds with the substrate backbone. In the case of the L.
lactis OppA, the binding cavity is exceptionally large.
The genome sequence of M. tuberculosis H37Rv reveals two
peptide permease operons encoded by Rv3665c-Rv3662c and
Rv1280c-1283c [13]. Disruption of the homolog of the Rv1280c to
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resulting mutant resistant to the toxic peptides glutathione and S-
nitrosoglutathione [13]. However, in their study, the authors did
not analyze the substrate-binding properties of the binding
protein, OppA in particular. On the other hand, broad substrate
specificity has been demonstrated for the three OppA proteins of
Borrelia burgdorferi [14].
In order to understand the biological roles of the putative
peptide importers of mycobacteria, we have cloned, expressed and
studied the substrate-binding properties of OppA of M. tuberculosis
(OppAMTB). We observe that OppA is capable of binding both the
tripeptide glutathione and the nonapeptide bradykinin. Based on
homology modeling and mutational analysis, we have identified
amino acid residues that are critical for substrate binding. Further,
we have used an oppA-knock out mutant (OppA-KO) of M.
smegmatis as a model system to demonstrate that the Opp
transporter is capable of importing glutathione. This observation
provided the motivation to test the possible role of this transporter
in M. tuberculosis that has infected macrophages. The detoxification
of reactive ketoaldehydes such as methylglyoxal (MG) by
glyoxalase I and II protects cells from formation of advanced
glycation end products (AGEs). Glutathione is a cofactor in these
reactions [15,16]. We contended that the import of glutathione by
bacilli in infected macrophages, could possibly affect the ability of
the macrophages to convert MG to lactate.
We present evidence that MG levels are lower in macrophages
infected with an oppD knock out (OppD-KO) of M. tuberculosis
compared to the wild type. In keeping with this, we observed
decreased apoptosis of macrophages infected with OppD-KO
compared with the wild type. Knock out of oppD also altered the
ability of the bacterium to trigger cytokine release from infected
macrophages. The release of TNF-a, IL-6 and IL-1b was
attenuated in the mutant compared to the wild type.
Materials and Methods
Molecular biological procedures
Standard procedures were used for cloning and analysis of
DNA, PCR and transformation. Electroporation in mycobacteria
was carried out using a Bio-Rad Gene Pulser as described by
Snapper et al. [17]. Enzymes used to manipulate DNA were from
Roche Applied Sciences. All constructs made by PCR were
sequenced to verify their integrity.
Bacterial strains and growth conditions
Escherichia coli strains were grown in Luria–Bertani (LB) Miller
(Difco) medium. Mycobacterial strains were grown in Middleb-
rook (MB) 7H9 (Difco) supplemented with 2% glucose, 0.05%
Tween 80 or Lemco medium supplemented with 0.05% Tween
80. Antibiotics were used at the following concentrations:
ampicillin, 75 mg/ml; kanamycin monosulfate, 50 mg/ml for E.
coli and 25 mg/ml for M. smegmatis; and hygromycin B, 100 mg/ml
for E. coli and 50 mg/ml for M. smegmatis.
Construction of expression plasmids for OppA
oppA (Rv1280c) of M. tuberculosis was amplified from cosmid
MTCY50 using the primer pair 59-TTT CTA GAC ATA TGG
CTG ACC GTG GCC AG-39 (sense) and 59- TCA GCG TCG
CAT GAA CCC GAT GGC-39 (antisense) and cloned into the
vector pK19 digested with SmaI to generate pOpp101. The
resulting construct was digested with NdeI and HindIII and the
excised fragment was cloned between the same sites of pET28a
+
(Novagen) to generate pOpp102. Mutants of oppA were generated
by overlap extension PCR. The primers used are given in Table
S1 with restriction sites in bold. The initial rounds of PCR were
carried out using primer pairs ‘‘a’’ and ‘‘b’’, and ‘‘c’’ and ‘‘d’’ and
pOpp102 as template. The products of each PCR were purified
and used as templates for the second round of PCR using primers
‘‘a’’ and ‘‘d’’. The final products were cloned between the NheI
and EcoR1 sites of pET28a
+ to generate mutants of OppA of M.
tuberculosis in pET 28a
+. The integrity of all constructs was checked
by sequencing.
Expression and purification of OppA
Recombinant plasmids derived from pET 28a
+ were trans-
formed in E. coli BL21(DE3). Cells were grown to an OD600 of 0.6.
IPTG was added to a final concentration of 250 mM and growth
was continued at 37uC with shaking for 2 h. Cells were harvested
and resuspended in 10 mM Tris-HCl (pH 7.4), 1 mM MgCl2,
1 mM PMSF, 20 mg/ml leupeptin, 10 mg/ml pepstatin and
10 mg/ml aprotinin, and disrupted by sonication. Recombinant
His-tagged proteins were purified from lysates by chromatography
on Ni
2+-NTA agarose.
In vitro binding assays
Purified OppA (1 mg) was added to a 25 ml reaction volume
containing the binding buffer (25 mM Na-phosphate (pH-6.5),
100 mM NaCl). 0.1 M DTT was added when using glutathione as
a substrate. The reaction was started by addition of 3,4(n)-
3H
bradykinin (specific activity 7 Ci/mmol, GE Healthcare), or
glutathione (specific activity 52 Ci/mmol, Perkin Elmer) at various
concentrations and continued at 25uC for 15 min. The reaction
mix was then subjected to TCA precipitation, the precipitate was
dried and counted in a liquid scintillation counter.
Uptake of [
3H] GSH
M. smegmatis cells were grown up to an OD600 of 0.6, washed in
basal salts containing 0.05% Tween 80, and concentrated to an
OD600 of 3.0. The cell suspension (1 ml) was warmed to 37uC with
shaking. The uptake reaction was initiated by the addition of
radiolabeled substrate along with unlabeled substrate at a specific
activity of 4.48 mCi/mmol and a final concentration of 100 mM.
Incorporation was terminated by removal of 0.1-ml samples at the
indicated time points, and filtration on Whatman GF/C (0.45-mm
pore size) filters prewetted with basal salts. The cells were quickly
washed thrice with 5 ml of ice-cold basal salts containing Tween
80 on a vacuum filtration manifold. Filters were counted in a
liquid scintillation counter. Uptake assays were performed in
triplicate.
Molecular modeling
Using the BLAST server (http://www.ncbi.nlm.nih.gov/BLAST/),
template structures homologous to OppA were sought, but no
appreciable homology was found in the Brookhaven pdb database.
Appropriate template structures were therefore chosen by comparing
the results of fold prediction servers 3DPSSM (http://www.sbg.bio.
ic.ac.uk/˜3dpssm/), GENTHREADER (http://bioinf.cs.ucl.ac.uk/
psiform.html), FFAS (http://www. bioinformatics.burnham-inst.
org/FFAS/index.html), UCLA-DOE (http://fold.doe-mbi.ucla.edu/
psiform/), BIOINBGU (http://www.cs.bgu.ac.il/˜bioinbgu/), and
FUGUE (http://www-cryst.bioc.cam.ac.uk/˜fugue/). The best tem-
plate which came out from these analyses was OppA of Salmonella
typhimurium complexed with the peptide KAK (pdb code 1JET). This
was used as template to model the structure of OppA of M. tuberculosis
(OppAMTB) using the software MODELER. The output was a 3D
model for the target sequence containing all main chain and side chain
non-hydrogen atoms. Amino acid residues I77 to R591 of OppAMTB
OppABCD of M. tuberculosis
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to lack of homology. A total of 20 models were generated and the final
model was selected based on its stereochemical properties. This model
was subjected to energy minimization using the Insight II Version 2000
(Accelrys Inc.) software package, using the steepest descent minimiza-
tion algorithm in the discover module of Insight II. The overall
stereochemical quality of the final models was assessed by the program
PROCHECK. The resolution was set at 1.5 A ˚.T h ef i n a lm o d e l sw e r e
verified through the program VERIFY 3D (http://www.doe-mbi.ucla.
edu/Services/Verify_3D/) and ERRAT (http://www.doe-mbi.ucla.
edu/Services/Errat.html).
Docking of OppA with glutathione and bradykinin
The co-ordinates of bradykinin were obtained from PRODRG
server and the docking was performed with AUTODOCK 3.0.5.
For docking of OppA with glutathione, the glutathione coordi-
nates were taken from glutathione-bound human glutathione-S
transferase structure (PDB ID: 1AQW) [18]. Bradykinin was
drawn with JME Molecular Editor using the PRODRG server
(http://davapc1.bioch.dundee.ac.uk/cgi-bin/prodrg_beta) and
the co-ordinate file was generated. All hydrogen atoms in both
protein and ligands were explicitly modeled, with polar hydrogen
atoms being assigned Lennard-Jones 12-10 hydrogen bonding
parameters and nonpolar hydrogen atoms being assigned 12-6
parameters. Hydrogen atoms were added to the OppA structure
using the builder module of the Insight II software package. All
water molecules were removed while docking. Partial charges were
assigned to the protein atoms using CVFF force field of Insight II.
Atomic solvation parameters and fragmental atom volumes were
added using the AddSol program provided in the Autodock 3.0.5
suite. The grid maps for van der Waals and electrostatic energies
were prepared using AutoGrid version 3.0 with 50644640 points
spaced at 0.375 distances. The active sites of several OppA crystal
structures were screened first and these were found to be similar.
Hence the grid was centered in the active site accordingly. The
main aim of this docking study was to identify the active site
residues by determining the bound conformation of glutathione/
bradykinin in the active site of OppA and correlating the result
with mutational analysis. All docking jobs were run on an SGI O2
with R5000 processor running IRIX 6.5.
Construction of suicidal delivery vector for inactivation of
oppA of M. smegmatis
M. smegmatis mc
2 155 oppA,- B,- C and –D are encoded by the
ORFs MSMEG_4999, MSMEG_4995, MSMEG_4996 and
MSMEG_4997 respectively. The unmarked deletion mutant of
oppA of M. smegmatis was constructed using the allelic replacement
method of Parish and Stoker [19]. Briefly, the oppA gene along
with its upstream sequence was PCR amplified in two steps to
create an in-frame deletion, from the genomic DNA of the wild
type. Fragment 1 was amplified with the primer pair 59-TAT AAG
CTT CGA CAA GTC CGC GCG CTC-39 (sense) and 59-TAA
TTC TAG AAC GGC TCG GCG AAC GTC A -39 (antisense)
and fragment 2 was amplified using the primer pair 59-ATA TTC
TAG AAG GCC AGG ACG ATG GCC AA -39 (sense) and 59-
TAG GAT CCT CGA CGA TGC GGG CGT CGG CA -39
(antisense) [restriction sites underlined]. Fragment 1 (1060 bp) was
cloned between the Hind III and XbaI sites of the vector pUC19
to generate pOpp201. Fragment 2 (1064 bp) was cloned between
the XbaI and BamHI sites of pOpp201 to generate pOPP202.
The 2.1 kb insert carrying the disrupted oppA gene (with a deletion
of 988 bp) was excised with HindIII and BamHI and cloned
between the same sites of p2NIL to generate pOpp203. The final
delivery vector pOpp204 was generated by cloning the PacI
cassette (hyg, pAg85- lac Z,p hsp60- sac B) excised from the vector
pGOAL 19 into the PacI site of pOPP203.
Isolation of the mutant inactivated in the oppA gene
Denatured pOpp204 DNA was electroporated into electro-
competent cells of M. smegmatis. The cells after electroporation
were revived in 5 ml of Lemco media for 3 h and then plated on
Lemco agar supplemented with hygromycin B, kanamycin and
50 mg/ml X-gal. Blue colonies appeared after 3 days. These were
replated onto Lemco agar without any selection to enhance the
recombination process. From the colonies that appeared on the
plates, a loopful of cells was taken and resuspended in Lemco
broth, mixed with vortexing, serial dilutions were plated onto
Lemco agar supplemented with 2% sucrose and 50 mg/ml X-gal
and allowed to grow for two days. The white colonies that
appeared after 2 days on the plates were then streaked onto 4
replica plates, the first supplemented with X-gal, the second with
kanamycin, the third with hygromycin B and the fourth with
sucrose. The white, kanamycin and hygromycin-sensitive, sucrose-
resistant colonies were identified, analyzed by PCR and candidate
opp A mutants were confirmed by Southern analysis.
Complementation of oppAMTB in the OppA-KO
Complementation of oppA was achieved by constructing an
integrating vector containing a hygromycin-resistance cassette
along with a positive-selection L5 integrase cassette. oppA of M.
tuberculosis (wild type or variants) was first cloned in pOLYG [20],
under the control of the hsp60 promoter and hsp60–oppA was
excised and cloned between the same sites in pUC19 to generate
pOPP205. A 3.7 kb Hyg-integrase cassette from pUC-HY-INT
[21], was cloned at the single HindIII site of pOpp205 to generate
the integrating vector pOpp206. pOpp206 was electroporated into
electrocompetent cells of the OppA-KO strain in order to
complement the mutant strain with a single copy of the wild type
oppA of M. tuberculosis. The presence of the oppAMTB gene was
confirmed by PCR with oppA-specific primers. Variants of
oppAMTB were similarly complemented in OppA-KO.
Construction of the M. tuberculosis oppD knock out
mutant
The M. tuberculosis oppD mutant was constructed by targeted
mutagenesis using a temperature sensitive-sacB delivery system as
described previously [22]. Amplification of the oppD gene along
with flanking regions was done in two steps to delete the conserved
functional sites. In the first step a 948 bp fragment of oppD along
with its upstream region was PCR amplified using the forward and
reverse primers 59- TAT ATC TAG AAC CGT TGA TCG CCA
ACG G -39 and reverse 59-T A G AAT TCG AGA ACG GCT
CGG CGA A -39 respectively and cloned in pBluescript SK
(Stratagene) between the XbaI and EcoRI sites (underlined) to
generate pOppD101. In the second step, a 1037 bp fragment
encoding the C-terminus of OppD along with the downstream
flanking region was amplified using the forward and reverse
primers 59-ATG AAT TCG GCA GGA TCA GCA GCC CGG A-
39 and 59-TAA AGC TTC TAG ATG CGC ACC GCC ATC-39
respectively and cloned in pOppD101 between the EcoRI and
HindIII sites (italicized) to generate pOppD102. pOppD102 was
digested with XbaI and ligated with a kanamycin resistance gene
excised from pUC4K to generate pOppD103. A 3.2 kb fragment
containing the disrupted oppD along with the kanamycin resistance
cassette was digested with XbaI and cloned into pPR27xylE which
harbors the sacB and xylE genes [22] to generate pOppD104. The
resulting vector, pOppD104 was electroporated into M. tuberculosis
OppABCD of M. tuberculosis
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plates. Single colonies were grown in broth at 32uC and then
plated on sucrose plates at 39uC. The resulting colonies were
analyzed by PCR and candidate oppD mutants were confirmed by
Southern analysis.
Complementation of oppDA of M. tuberculosis in the
OppD-KO
Since the oppA gene is downstream of oppD, its expression was
blocked in the OppD-KO. Complementation was therefore
carried out with oppDA by constructing an integrating vector
containing a hygromycin-resistance cassette along with a positive-
selection L5 integrase cassette. The oppDA coding region of M.
tuberculosis was PCR amplified in two fragments. The first fragment
was amplified with the primer pair 59-TAG AAT TCA TAT GAG
CCC CCT GCT CGA-39 (sense) and 59-GGG GCG CAG CCT
CGT CGC TGG CCA-39 (antisense) and cloned between the sites
EcoRI and SmaI sites of the vector pUC19 to generate the
construct pOppD105. The second fragment was amplified with
the primer pair 59-GGG CAT CGC GTC TGC GCT CAG
GGC GTC-39 (sense) and 59-TAT AAG CTT TCA GCG TCG
CAT GAC CCC-39 (antisense) and cloned between the SmaI and
HindIII sites of pOppD105. The resulting construct pOppD106
was digested with NdeI and HindIII and the excised fragment
containing the oppDA region was cloned under the hsp promoter of
an E. coli- mycobacteria shuttle vector digested with the same
enzymes to generate the construct pOppD107. hsp60–oppDA was
excised with XbaIandHindIII and cloned betweenthe same sitesin
pUC19 to generate pOppD108. The 3.7 kb Hyg-integrase cassette
from pUC-HY-INT was cloned at the single HindIII site of
pOppD108 to generate the integrating vector pOppD109.
pOppD109 was electroporated into electrocompetent cells of the
knockout strain in order to complement the mutant strain with a
single copy of the wild type oppDA of M. tuberculosis. The presence of
the oppDA gene was confirmed by PCR with oppDA-specific primers.
Cell death ELISA
Differentiated THP-1 cells were plated in 96 well plates (10
5 cells/
well). Wild type M. tuberculosis H37Rv or OppD-KO was grown in
MB 7H9 medium supplemented with ADC and 0.05% Tween 80 for
2 days for getting a well dispersed culture having O.D.600 value
between 0.2 and 0.4. Infection at the indicated MOI was done for
2 h; cells were washed twice with 1X RPMI to remove the
unphagocytosed bacteria. For determination of CFUs, cells were
solubilized in 0.06% SDS, lysates were serially diluted and plated. At
the MOIs used, there was a linear relationship between the MOI and
the actual number of bacteria infecting macrophages. Fresh medium
was added to each well and medium was changed every day. Finally,
cells were lysed with lysis buffer supplied with the cell death ELISA kit
(Roche Applied Science). ELISA was performed according to the
manufacturer’s protocol.
Determination of methylglyoxal (MG) Levels in THP-1
cells
Measurement of MG levels was performed as described by
Rachman et al. [23] with some modifications. THP-1 cells were
infected with wild type M. tuberculosis or the oppD knockout (OppD-
KO) at an MOI of 20:1 for 2 h. One day after infection, THP-1
Figure 1. Purification of OppAMTB and its binding with glutathione and bradykinin. (A) Coomassie blue-stained SDS gels showing
uninduced, induced E. coli lysates expressing His-OppAMTB, and purified His-OppAMTB. Protein marker sizes are indicated on the left side of the gel.
(B,C) In vitro binding assay was carried out with purified OppAMTB using radiolabeled glutathione (B) or bradykinin (C) in the absence (no inhibitor) or
presence of unlabeled dipeptide or glutathione (1 mM) as indicated. Data are presented taking the binding in the absence of inhibitor as 100%.
Results represent the means 6 S.D. of three determinations.
doi:10.1371/journal.pone.0012225.g001
OppABCD of M. tuberculosis
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sonication in PBS. Perchloric acid (PCA) (Merck) and o-
phenylenediamine (Across) were added to a final concentration
of 0.5 M and 5 mM, respectively. The mixture was incubated at
20uC for 24 h. The PCA precipitate was removed by centrifuga-
tion at 12,0006g. The supernatant was passed through a C18 solid
phase extraction cartridge (Waters Sep-Pak C18 plus cartridge,
Millipore), which had been flushed with 6–8 ml of acetonitrile and
6–8 ml of 10 mM KH2PO4 (pH 2.5). The sample was eluted from
the cartridge with 4 ml acetonitrile (Sigma). The quinoxaline
derivative of methylglyoxal (2-MQ) and the quinoxaline internal
standard (5-MQ) (Across) were measured using an Adsorbosphere
25 cm C-18 column (4.6 mm internal diameter and 5 mm particle
diameter) on a Waters chromatography system. The mobile phase
was 68 vol% of 10 mM KH2PO4 (pH 2.5) and 32 vol% of
acetonitrile. The analysis conditions were as follows: detector
wavelength, 315 nm; mobile phase flow rate, 1.0 ml/min; typical
sample size, 150 ml; and column temperature, 20uC. Duplicate
injections of each sample were made. Samples were calibrated
with a 2-MQ internal standard. The average retention times of 2-
MQ and 5-MQ were 6.3 and 8.5 min, respectively. Increase in
MG was determined by calculating the ratio of peak areas between
cells with and without infection. The ratio was normalized with the
ratio of the corresponding cell numbers.
Measurement of intracellular glutathione level
Glutathione was measured using the Glutathione Fluorimetric
Detection Kit (Abcam, UK) according to the manufacturer’s
protocol. Briefly, 10
6 differentiated THP-1 cells were infected and
lysed by treating with 100 ml of ice cold lysis buffer. The cell lysate
was diluted and mixed with GST reagent and MCB dye (supplied
by the manufacturer). After an incubation of 30 min at 37uC,
fluorescence was measured with excitation at 380 nm and
emission at 460 nm.
Results
Binding specificity of OppA
The annotated M. tuberculosis genome indicates the presence of
two peptide permeases opp (Rv1280c-Rv1283c)[ Rv1280c (oppA),
Rv1281c (oppD), Rv1282c (oppC), Rv1283c (oppB)and dpp (Rv3665c-
Rv3662c). Recent studies on M. bovis BCG suggest that the opp
operon encodes an oligopeptide transporter [24]. On the other
hand, Flores-Valdez et al. [25], have argued that Rv3665c-Rv3662c
encodes the oligopeptide transporter of M. tuberculosis, and that the
Rv1280c-Rv1283c operon likely encodes a dipeptide transporter.
Their arguments rely on the fact that an Rv3665c-Rv3662c
knockout mutant is resistant to bialaphos. However, no binding
studies for the substrate-binding components of these transporters
have been reported by this group. We undertook a more detailed
analysis of the Rv1280c-Rv1283c operon. As a first step, we
attempted to characterize OppA in terms of its binding specificity.
Figure 2. Mutational analysis of glutathione-binding ability of
OppAMTB. Binding of recombinant wild type (WT) OppAMTB or its
mutants to radioactive glutathione was studied as described under
‘‘Materials and Methods.’’ Binding of glutathione to OppAMTB (WT) was
set at 100%. Results represent the means 6 S.D. of three determinations.
doi:10.1371/journal.pone.0012225.g002
Figure 3. Glutathione uptake in M. smegmatis. (A) Southern analysis of wild type (WT) and OppA-KO of M. smegmatis. (B) M. smegmatis WT,
OppA-KO and OppA-KO complemented (com.) with oppAMTB [wild type or the indicated mutants] were grown upto logarithmic phase, harvested,
washed and incubated with radiolabeled glutathione at 37uC. Aliquots were withdrawn at the indicated time points and uptake was studied by
measuring the radioactivity incorporated in the cells (as described under Materials and Methods). Results represent the means 6 S.D. of three
determinations.
doi:10.1371/journal.pone.0012225.g003
OppABCD of M. tuberculosis
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are 68% identical (as analyzed using the BLAST algorithm) [26]
(Fig. S1). A putative signal peptide was predicted at residues 34–46
of OppAMTB using the programme Emboss sigcleave (http://
emboss.bioinformatics.nl/cgi-bin/emboss/sigcleave). OppAMTB
(Gene Bank accession number CAB00902) was expressed and
purified as an N-terminal His-tagged protein in E. coli BL21(DE3)
(Fig. 1A). This recombinant OppAMTB was devoid of the first 56
residues.
The L. lactis OppA has been reported to transport peptides from
4 upto 18 residues, including the nonapeptide bradykinin,
reflecting its versatility [27]. We tested whether OppAMTB
transports the nonapeptide bradykinin (RPPGFSPFR). An in vitro
binding assay using radioactive bradykinin at a concentration of
1 mM showed that OppAMTB binds 3661.5 pmol bradykinin/mg
protein (n=3).
Next, considering a previous report indicating that the Opp
transport system is involved in uptake of GSH in M. bovis BCG
[24], we tested the ability of OppAMTB to bind glutathione. At a
concentration of 1 mM GSH, OppA bound 14661 pmol GSH/
mg protein, suggesting that the tripeptide is preferred over the
bulkier nonapeptide bradykinin. The GSH-derived dipeptide glu-
cys was a more efficient competitor of GSH binding than the
peptide cys-gly (Fig. 1B). GSH and its peptides could also
competitively inhibit bradykinin binding (Fig. 1C). In summary,
the above results show that OppAMTB is capable of binding to
peptides of varying size. However, it likely prefers the smaller
peptides as substrates.
Homology modeling and mutational analysis of OppAMTB
Sequence similarity searches showed that OppAMTB is 22.1%
identical to OppA of S. typhimurium and 21% to OppA of B. subtilis.
The three dimensional structures of OppA proteins are likely more
conserved between different species than their primary amino acid
sequences. Based on this premise, a three-dimensional model of
OppA was built on the basis of fold prediction results. The model
encompasses residues I77 to R591. OppAMTB showed three
domains selected on the basis of clustering of folds. Domains I and
III (Fig. S2) are similar to the corresponding domains in many
substrate binding proteins and the interface between domains I
and III likely comprises the peptide binding pocket. For the
substrate binding proteins of the oligopeptide importers, peptide
binding usually involves hydrogen bonding between binding
pocket amino acid residues of the protein and the main chain of
the ligand [9].
Docking of OppA was carried out with both bradykinin and
glutathione as ligands. Docking analyses suggested that the
interactions of OppA with ligands involve binding pocket
residues containing amide or hydroxyl groups as hydrogen
bond donors/acceptors. Amino acids I107, D108, G109,
N110, V114, A115, N230, and G231 (present in domain I),
S194 and M226 (present in domain II), and W491 and F496
(present in domain III) were predicted to be involved in
binding to GSH. Most of these residues were also predicted to
be involved in binding of bradykinin. Several of these residues
were therefore chosen for mutational analyses. In addition, the
residue D494, conserved between M. tuberculosis and B. subtilis
OppA was also chosen for mutation since it is partially exposed
in the peptide binding pocket of OppA of B. subtilis.T h e
mutations G109S, N110A, N230G, F496D and D494N
resulted in more than 50% loss of GSH or bradykinin binding
activity (Fig. 2). Mutation N230G affected GSH binding
possibly due to the lowering of backbone interaction between
the amino acid at position 230 and GSH. Docking analyses
suggested that the N-terminal Glu of GSH is important for
binding with OppA. This supported our observation that the
peptide Glu-cys was a better competitor of GSH for binding to
OppA than the peptide Cys-gly.
Figure 4. Glutathione uptake in M. tuberculosis and glutathione
level in infected THP-1 cells. (A) Southern analysis of wild type and
OppD-KO of M. tuberculosis. (B) M. tuberculosis wild type (WT), OppD-KO
(KO) or OppD-KO complemented with oppDAMTB (com.) was grown
upto logarithmic phase, harvested, washed and incubated with
radiolabeled glutathione at 37uC. Aliquots were withdrawn at the
indicated time points and uptake was studied by measuring the
radioactivity incorporated in the cells (as described under ‘‘Materials
and Methods’’). (C) Glutathione pool was measured in uninfected or
infected THP-1 macrophages as described under ‘‘Materials and
Methods’’. Results represent the means 6 S.D. of three determinations.
doi:10.1371/journal.pone.0012225.g004
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smegmatis
OppA is conserved across both pathogenic and non-pathogenic
mycobacterial species suggesting that its function is likely to be
conserved. OppA of M. tuberculosis and M. smegmatis are 81% similar
and 68% identical. In view of this, we used the fast-growing
nonpathogenic M. smegmatis as a model organism to further investigate
the effect of mutations of OppA on peptide transport in mycobacteria.
Knockout of oppA was confirmed by Southern hybridization (Fig. 3A).
OppA-KO was complemented with a single copy of His-oppAMTB or its
mutants by integration into the chromosome of M. smegmatis using the
integrating vector pOPP206 harboring the His-oppAMTB gene under
the control of the hsp60 promoter.
Glutathione uptake in OppA-KO
In order to study the effects of mutations in OppA, the uptake of
[
3H]GSH was measured in OppA-KO and OppA-KO complement-
ed with wild type or mutant versions of oppAMTB.[
3H]GSH uptake was
lower in OPPA-KO compared to the wild type (Fig. 3B). Comple-
mentation with wild type oppAMTB restored [
3H]GSH uptake to levels
similar to the wild type. However, complementation with the mutants
N110A, N230G, F496D or D494N, did not restore GSH uptake
(Fig. 3B). The G109S mutant could partially reverse loss of GSH
uptake ability of OppA-KO. These results supported those obtained by
in vitro binding assays and also the view that the Opp importer plays a
major role in uptake of glutathione by M. smegmatis.
Glutathione uptake in M. tuberculosis
The oppD gene of M. tuberculosis, encoding the two ATP binding
components of the transporter, was disrupted by deletion and
insertion of a kanamycin resistance cassette and confirmed by
Southern hybridization (Fig. 4A). Since oppA is located down-
stream of oppD, the insertion of the kanamycin resistance cassette,
also blocked expression of oppA. An oppDA-complemented strain
was constructed by inserting a copy of oppDA into the chromosome
of H37Rv using the integrating vector pOppD109 harboring the
oppDA genes under the control of the hsp60 promoter. The growth
rates of the knockout and complemented strains were comparable
to the wild type in vitro (Fig. S3).
Just as in the case of M. smegmatis, uptake of [
3H}GSH was
compromised in the OppDA-KO mutant of M. tuberculosis compared
to the wild type (Fig. 4B). Uptake was restored upon complemen-
tation with oppDA. This result supported the view that the Opp
transporter of M. tuberculosis is also capable of importing GSH. We
next tested the hypothesis that GSH uptake by the Opp importer of
M. tuberculosis residing in macrophages may deplete the macrophage
GSH pool, by comparing macrophage GSH content after infection
by wild type M. tuberculosis or the OppD-KO. The GSH pool was
significantly depleted in macrophages infected with M. tuberculosis
compared to uninfected macrophages (Fig. 4C). The extent of
depletion of GSH was greatly reduced when macrophages were
infected with OppD-KO, whereas the oppDA-complemented strain
behaved like the wild type. Intracellular GSH levels are significantly
reduced in PBMCs from tuberculosis patients compared to normal,
healthy controls [28]. Our results suggest that import of GSH by the
Opp importer is likely to contribute to this phenomenon.
Methyl glyoxal (MG) levels in M. tuberculosis H37Rv and
OppD-KO
During mycobacterial infection of macrophages, the cellular
levels of methyl glyoxal (MG) [a physiological product of various
metabolic pathways] [29], are elevated. Since GSH is required for
the conversion of MG to lactate, we speculated that GSH import
by M. tuberculosis could impair the ability of the macrophage to
detoxify MG. Based on this premise, we assessed MG levels after
infection of macrophages (at an MOI of 20) with wild type M.
tuberculosis H37Rv, OppD-KO and the complemented strains. In
three independent experiments, MG levels were 4.8 times higher
in wild type M. tuberculosis-infected macrophages compared to
uninfected macrophages, whereas MG levels were 1.5 times higher
(over uninfected macrophages) in OppD-KO- infected cells. MG
levels were restored to that observed in macrophages infected with
the wild type, when OppD-KO was complemented with oppDA of
M. tuberculosis (Fig. 5). These observations suggested that expression
of the OppABCD importer of M. tuberculosis was correlated with
MG levels in infected macrophages.
Macrophages infected with OppD-KO produce lower
amounts of TNF-a, IL-1b and IL-6 and undergo reduced
apoptosis compared to the wild type
Based on previous reports that MG production is associated
with elevated levels of inflammatory cytokine production, we
Figure 5. Methlglyoxal (MG) levels in macrophages after infection with M. tuberculosis. Differentiated THP-1 cells were infected with M.
tuberculosis H37Rv (WT), OppD-KO (KO) or OppD-KO complemented with oppDAMTB (COM.) at an MOI of 20 for 2 h. Unphagocytosed bacteria were
removed, cells were washed, incubated for 24 h in fresh medium, lysed and MG levels were determined in the lysate by HPLC [as 2-methylquinoxaline
(2-MQ)] as described under ‘‘Materials and Methods’’ and by Rachman et al. [23]. 5MQ was used as an internal standard. The chromatograms are
representative of the results obtained from three separate sets of experiments.
doi:10.1371/journal.pone.0012225.g005
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with wild type M. tuberculosis or OppD-KO at an MOI of 20. At
this MOI, cells were treated with bacteria for 2 h, washed, lysed
and bacterial load was determined. Comparable CFUs of
1.4610
4, 1.5610
4 and 1.3610
4 bacteria per 10
5 macrophages
were obtained for the wild type, OppD-KO and complemented
strains respectively. After 24 h, OppD-KO infection led to lesser
amounts of TNF-a, IL-1b and IL-6 production in macrophages
compared to the wild type (Fig. 6A-C). These observations were in
line with reports that MG levels regulate cytokine production from
macrophages. No significant differences were observed in the
production of IFN-b, MCP-1, IL-10, IL-8 and RANTES (data not
shown).
Since TNF-a is a known proapoptotic cytokine, we tested for
observable differences in apoptosis of macrophages infected with
M. tuberculosis H37Rv or OppD-KO. Apoptosis was lower in
macrophages infected with OppD-KO compared to the wild type
(Fig. 6D).
Discussion
Peptide import is likely to be an important process in the biology
of the mycobacteria as for other bacteria. Streptomyces coelicolor and
Corynebacterium glutamicum, two species belonging to the same
taxonomic order as mycobacteria, have often provided important
clues regarding functions of gene products in the pathogen M.
tuberculosis.I nStreptomyces, the oligopeptide transport system, Opp
imports an oligopeptide that is likely involved in regulating
development [30]. Signaling molecules that likely regulate
processes such as entry into and exit out of dormancy in
mycobacteria, remain to be identified. Whether the peptide
importers play any role in developmental processes in mycobac-
teria, remains open to question. As a step in this direction, we
undertook characterization of one of the putative peptide
transporters of M. tuberculosis, annotated as an ABC transporter
oppABCD, where oppA encodes the substrate binding lipoprotein. In
this study we confirm that OppA is a peptide-binding protein. We
present evidence that OppA binds to a wide range of peptides in
terms of their size, ranging from the nonapeptide bradykinin to the
tripeptide GSH. It shows a preference for binding glutathione
compared to bradykinin, In addition, we demonstrate that GSH-
derived dipeptides can compete for peptide binding, suggesting
that the substrate specificity extends to dipeptides as well. Our
results differ somewhat from those of Flores-Valdez et al. (2009)
who have argued that OppABCD is a dipeptide transporter. Using
homology modeling to predict amino acid residues of the peptide-
binding pocket of OppA, followed by mutational analysis, we
demonstrate that amino acid residues G109, N110, N230, D494
and F496 are involved in peptide binding. Microarray expression
profiling has clearly shown that the Rv3665c-Rv3663c locus in M.
tuberculosis regulates at least some genes which are induced during
nutrient deprivation and hypoxia [24]. It would be of considerable
interest to analyze the transcriptome of the OppD-KO strain
described by us under different growth conditions.
Most importantly, we report the fortuitous observation of a
novel role of OppABCD in modulating the outcome of M.
tuberculosis-macrophage interactions. Increase in the macrophage
MG levels (over the level in uninfected macrophages) is 4.8 fold in
the case of macrophages infected with the wild type vs. 1.5 fold in
the case of macrophages infected with OppD-KO. TNF-a
stimulates the production of reactive oxygen intermediates (ROI)
[31]. TNF-a production by M. tuberculosis could therefore impair
GSH-redox status by production of ROI. Our studies suggest that
in addition to the aforesaid mechanism, other mechanisms exist
Figure 6. Attenuation of cytokine release and mycobacteria-
induced apoptosis in differentiated THP-1 cells by OppD-KO
cells. Differentiated THP-1 cells were infected with M. tuberculosis
H37Rv, the isogenic OppD-KO or OppD-KO complemented with oppDA
at an MOI of 1:20 as described under ‘‘Materials and Methods’’ (A–C).
After 24 h, cytokine release was measured in the supernatants using
cytokine assay ELISA kits, or (D) cells were washed, lysed, and cell death
was measured using the Cell Death ELISA kit (Roche) as described under
‘‘Materials and Methods’’. Results of cell death assays are expressed as
the fold increase in the release of histone compared to untreated THP-1
cells. Results represent the means 6 S.D. of three determinations.
doi:10.1371/journal.pone.0012225.g006
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uptake by mycobacteria through the opp system could be one such
mechanism. The O’Connell laboratory has shown that GSH is
toxic to ‘‘in-vitro grown’’ M. bovis BCG [13]. However, our studies
pertain to M. tuberculosis H37Rv rather than to M. bovis BCG. The
O’Connell laboratory has shown hypersurvival of the dpp mutant,
suggesting that this could be due to the impaired ability of the
mutant to import glutathione. It could just as well be contended
that the differences in CFU occur because of attenuated apoptosis
of macrophages infected with the dpp mutant. Death of
macrophages would rob the bacterium of its niche for replication,
therefore accounting for differences in CFU between the two
strains.
Apoptosis of macrophages in granulomas in TB patients, is
induced by an environment rich in MG. Rachman et al. [23] have
shown that pretreatment with GSH leads to significant reduction
in mycobacteria-induced apoptosis. Glutathione uptake by
mycobacteria through the opp system could therefore contribute
towards enhanced apoptosis of infected macrophages. Mycobac-
teria-induced apoptosis was studied by infecting differentiated
THP-1 cells with wild type M. tuberculosis, OppD-KO, and the
oppDA-complemented strain. There was marked reduction of
apoptosis of macrophages infected with OppD-KO compared
with the wild type and restoration of the apoptosis-inducing ability
in the complemented strain. We contend that the reduced
glutathione uptake by OppD-KO increases GSH levels inside
the macrophages compared to cells infected with the wild type
strain, thereby facilitating detoxification of MG. As a result,
apoptosis in OppD-KO-infected macrophages is reduced in
comparison with macrophages infected with the wild type M.
tuberculosis. MG is associated with the induction of inflammatory
cytokines such as TNF-a [32]. Our results suggest that import of
GSH by the OppABCD importer, and subsequent impairment of
MG-detoxification in infected macrophages, contributes to
enhanced production of inflammatory cytokines such as TNF-a,
IL-6 and IL-1b. This is partly rescued in OppD-KO. We contend
that these are not non-specific effects due to differences in CFUs
for wild type and OppD-KO grown in macrophages, since the
observations are restricted to a subset of cytokines.
Apoptosis of host macrophages is required for established an
effective immune response against tuberculosis [33]. Our obser-
vations therefore suggest that it would be of interest to compare
the ability of the oppD mutant to cause disease and maintain
bacterial burden during both the chronic and the persistent phases
of infection.
Supporting Information
Table S1 Primers for amplification of derivatives of OppA of M.
tuberculosis.
Found at: doi:10.1371/journal.pone.0012225.s001 (0.01 MB
PDF)
Figure S1 Blast analysis of OppA of M. tuberculosis and M.
smegmatis.
Found at: doi:10.1371/journal.pone.0012225.s002 (0.01 MB
PDF)
Figure S2 Stereoview of the model of M. tuberculosis OppA.
Found at: doi:10.1371/journal.pone.0012225.s003 (0.21 MB
PDF)
Figure S3 Growth curves of wild type M. tuberculosis, OppD-KO
and oppDA-complemented OppD-KO.
Found at: doi:10.1371/journal.pone.0012225.s004 (0.04 MB
PDF)
Acknowledgments
The authors would like to thank Dr. Richard Stokes for pUC-HY-INT,
Drs. Neil Stoker and Tanya Parish for p2NIL and pGOAL vectors and Dr.
Stewart Cole for MTCY50.
Author Contributions
Conceived and designed the experiments: AKD PC MJ BG MK JB.
Performed the experiments: AD KS DM BS SS MK. Analyzed the data:
AD KS DM BS AKD MJ MK JB. Wrote the paper: MK JB.
References
1. Higgins CF (1992) ABC transporters: from microorganisms to men. Annu Rev
Cell Biol 8: 67–113.
2. Saurin W, Hofnung M, Dassa E (1999) Getting in or out: early segregation
between importers and exporters in the evolution of ATP-binding cassette (ABC)
transporters. J Mol Evol 48: 22–41.
3. Alloing G, de Philip P, Claverys JP (1994) Three highly homologous membrane-
bound lipoproteins participate in oligopeptide transport by the Ami system of the
Gram-positive Streptococcus pneumoniae. J Mol Biol 241: 44–58.
4. Perego M, Higgins CF, Pearce SR, Gallagher MP, Hoch JA (1991) The
oligopeptide transport system of Bacillus subtilis plays a role in the initiation of
sporulation. Mol Microbiol 5: 173–185.
5. Rudner DZ, Le Deaux JR, Treton K, Grossman AD (1991) The spoOK locus of
Bacillus subtilis is homologous to the oligopeptide permease locus and is required
for sporulation and competence. J Bacteriol 173: 1388–1398.
6. Tynkkynen S, Buist G, Kunji E, Kok J, Poolman B, et al. (1993) Genetic and
biochemical characterization of the oligopeptide transport system of Lactococcus
lactis. J Bacteriol 175: 7523–7532.
7. Biemans-Oldehinkel E, Doeven MK, Poolman B (2006) ABC transporter
architecture and regulatory roles of accessory domains. FEBS Lett 580:
1023–1035.
8. Nickitenko A, Trakhanov S, Quiocho F (1995) 2A
o resolution structure of DppA,
a peiplasmic dipeptide transport/chemosensory receptor. Biochemistry 34:
16585–16595.
9. Tame JRH, Dodson EJ, Murshudov G, Higgins CF, Wilkinson AJ (1995) The
crystal structures of the oligopeptide-binding protein OppA complexed with
tripeptide and tetrapeptide ligands. Structure 3: 1395–1406.
10. Tanabe M, Mirza O, Bartrand T, Atkins HS, Titball RW, et al. (2007)
Structures of OppA and PstS from Yersinia pestis indicate variability of
interactions with transmembrane domains. Acta Crystallogr D Biol Crystallogr
63: 1185–1193.
11. Levdikor VM, Blagora EV, Brannigan JA, Wright L, Vagin AA (2005) The
structure of the oligopeptide-binding protein, AppA from Bacillus subtilis in
complex with a nonapeptide. J Mol Biol 345: 879–892.
12. Berntsson RPA, Doeven MK, Fusetti F, Duurkens RH, Sengupta D, et al. (2009)
The structural basis for peptide selection by the transport receptor OppA.
EMBO J 28: 1332–1340.
13. Green RM, Seth A, Connell ND (2000) A peptide permease mutant of
Mycobacterium bovis BCG resistant to the toxic peptides glutathione and S-
nitrosoglutathione. Infect Immun 68: 429–436.
14. Wang XG, Kidder M, Scagliotti JP, Klempner MS, Noring R, et al. (2004)
Analysis of differences in the functional properties of the substrate binding
proteins of the Borrelia burgdorferi oligopeptide permeases (opp) operon. J Bacteriol
186: 51–60.
15. Thornally PJ (1988) Modification of the glyoxylase system in human red blood
cells by glucose in vitro. Biochem J 254: 751–755.
16. Davidson SD, Milanesa DM, Mallouh C, Choudhury MS, Tazaki H, et al.
(2002) A possible regulatory role of glyoxylase I in cell viability of human
prostate cancer. Urol Res 30: 116–121.
17. Snapper SB, Melton RE, Mustafa S, Kieser T, Jacobs, WR Jr (1990) Isolation
and characterization of efficient plasmid transformation mutants of Mycobacterium
smegmatis. Mol Microbiol 4: 1911–1919.
18. Prade L, Hof P, Bieseler B (1997) Dimer interface of glutathione S-transferase
from Arabidopsis thaliana: influence of the G-site architecture on the dimer
interface and implications for classification. Biol Chem 378: 317–320.
19. Parish T, Stoker NG (2000) Use of a flexible cassette method to generate a
double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene
replacement. Microbiology 146: 1969–1975.
20. O’Gaora P, Bernini S, Hayward C, Filley E, Rook G, et al. (1997) Mycobacteria
as immunogens: development of expression vectors in multiple mycobacterial
species. Med Princ Pract 6: 91–96.
OppABCD of M. tuberculosis
PLoS ONE | www.plosone.org 9 August 2010 | Volume 5 | Issue 8 | e1222521. Mahenthiralingam E, Marklund BI, Brooks LA, Smith DA, Bancroft GJ, et al.
(1998) Site-directed mutagenesis of the 19-kilodalton lipoprotein antigen reveals
no essential role for the protein in the growth and virulence of Mycobacterium
intracellulare. Infect Immun 66: 3626–3634.
22. Pelicic V, Reyrat JM, Gicquel B (1996) Generation of unmarked directed
mutations in mycobacteria, using sucrose counter-selectable suicide vectors. Mol
Microbiol 20: 919–925.
23. Rachman H, Kim N, Ulrichs T, Baumann S, Pradl L, et al. (2006) Critical Role
of methylglyoxal and AGE in mycobacteria-induced macrophage apoptosis and
activation. PLos ONE 1: 1–8, e29.
24. Green RM, Seth A, Connell ND (2000) A peptide permease mutant of
Mycobacterium bovis BCG resistant to the toxic peptides glutathione and S-
nitrosoglutathione. Infect Immun 68: 429–436.
25. Flores-Valdez MA, Morris RP, Laval F, Daffe M, Schoolnik GL (2009)
Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease
(Opp) transport system. FASEB J 23: 4091–4104.
26. Altschul SF, Koonin EV (1998) Iterated profile searches with PSI-BLAST–a tool
for discovery in protein databases. Trends Biochem Sci 23: 444–447.
27. Detmers FJM, Lanfermeijer FC, Abele R, Jack RW, Tampe R, et al. (2000)
Combinatorial peptide libraries reveal the ligand-binding mechanism of the
oligopeptide receptor OppA of Lactococcus lactis. Proc Natl Acad Sci USA 97:
12487–12492.
28. Venketaraman V, Millman A, Salman M, Swaminathan S, Goetz M, et al.
(2008) Glutathione levels and immune responses in tuberculosis patients. Microb
Pathog 44: 255–61.
29. Thornalley PJ (2008) Protein and nucleotide damage by glyoxal and
methylglyoxal in physiological systems- role in ageing and disease. Drug
Metabol Drug Interact 23: 125–150.
30. Nodwell JR, McGovern K, Losick R (1996) An oligopeptide permease
responsible for the import of an extracellular signal governing aerial mycelium
formation in Streptomyces coelicolor. Mol Microbiol 22: 881–893.
31. Kim YS, Morgan MJ, Choksi S, Liu Z (2007) TNF-induced activation of the
Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol
Cell 26: 675–687.
32. Abordo EA, Thornalley PJ (1997) Synthesis and secretion of tumour necrosis
factor-a by human monocyte THP-1 cells and chemotaxis induced by human
serum albumin derivatives modified with methylglyoxal and glucose-derived
advanced glycation end products. Immunology Letters 58: 139–147.
33. Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, et al. (2003)
Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and
CD1 in tuberculosis. Nat Med 9: 1039–1046.
OppABCD of M. tuberculosis
PLoS ONE | www.plosone.org 10 August 2010 | Volume 5 | Issue 8 | e12225